Skip to content
Search

Latest Stories

Silent suffering: 12k NHS staff reluctant to share mental health and well-being struggles

Silent suffering: 12k NHS staff reluctant to share mental health and well-being struggles
Latest UNISON survey underscores mental health absence affecting over 30 per cent of NHS staff including paramedics, and nurses

A recent UNISON survey has unveiled the alarming impact of mental health issues on NHS employees, exacerbating the ongoing staffing crisis in the healthcare sector.

The survey, encompassing over 12,000 health workers across the UK, revealed that more than three in ten (31 per cent) NHS staff had to take time off work due to mental health issues in the past year.


Nurses, paramedics, and other healthcare workers reported experiencing a range of mental and physical symptoms, including depression, panic attacks, high blood pressure, and sleepless nights.

Despite the prevalence of these issues, the survey highlighted a concerning stigma surrounding mental health, with one in five employees concealing the real cause of their absence.

Among the reasons cited for this reluctance were concerns about the lack of support from managers or employers (45 per cent) and fear of judgment from colleagues (22 per cent).

Helga Pile, UNISON's head of health, emphasized the urgent need for action to address the overwhelming pressures faced by NHS staff.

She said, "Many NHS staff are clearly at their limit. Burnout is a reality in every part of the health service, from hospital wards to ambulance stations."

She underscored the importance of recognizing the value of healthcare workers and implementing measures to support their well-being, including safer staffing levels, measures to combat bullying and harassment, and access to mental health support services.

Responding to the survey, Dr. Ananta Dave, the Royal College of Psychiatrists’ Presidential Lead for Wellbeing and Retention, emphasized the toll that "burnout" is taking on NHS employees.

"Our own members report struggling with increasingly unmanageable workloads due to rising demand. They are under intense pressure which has been exacerbated by chronic staff vacancies and often don’t have enough colleagues they can rely on for support," he said.

While noting that "a significant portion of staff also did not feel comfortable sharing their concerns with their manager", he further called  for prioritizing initiatives to address staff shortages, silent suffering, and ensure adequate support for mental health and well-being, including sustained funding for NHS staff mental health and wellbeing hubs.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less